Oragenics logo

Oragenics

OGENAMEX

Oragenics is a biotechnology company in the healthcare sector on AMEX, led by Janet Huffman, with a market cap of $3.4M. As of Q3 2025, 3% of shares are held by 15 institutional investors, with DRW Securities, LLC as the largest holder at 1.5%.

Interim Principal Executive Officer and PresidentJanet Huffman
Market Cap$3.4M
Biotechnology
Healthcare
Employees5.0
Country
United States of America

Overview

Overview of institutional ownership in OGEN as of Q3 2025 with a market cap of $5.4M

All Institutions

Institutions
15
Value Held
$160.5K
Shares Held
122.5K
Avg Position
$10.7K
Median Position
$47.0

Hedge Funds

Hedge Funds
1
Value Held
$1.0
Shares Held
1.0
Avg Position
$1.0
Median Position
$1.0

Ownership Breakdown

Institutional (non-HF): 2.97%Hedge Funds: 0.00%Retail & Other: 97.03%Retail & Other
Institutional (non-HF)
2.97%
$160.5K
Hedge Funds
0.0%
$1.0
Retail & Other
97.03%
$5.2M

Based on market cap of $5.4M as of Q3 2025. Institutional (non-HF) excludes hedge funds to avoid double counting.

Biggest Investors

Institutions with the largest positions in OGEN as of Q3 2025

InstitutionPosition Value
$81.0K
0.00% of portfolio
$77.2K
0.42% of portfolio
BlackRock, Inc. logo
BlackRock, Inc.
Institution
$921.0
0.00% of portfolio
$438.0
0.00% of portfolio
UBS Group AG logo
UBS Group AG
Institution
$355.0
0.00% of portfolio
$272.0
0.00% of portfolio
MORGAN STANLEY logo
MORGAN STANLEY
RIA/Wealth
$181.0
0.00% of portfolio
$47.0
0.00% of portfolio
$45.0
0.00% of portfolio
$45.0
0.00% of portfolio

Net Capital Flow

Institutional buying and selling activity for OGEN in Q3 2025

Traded
+$151.0K
Buyers
7
Sellers
6
Total Bought
+$158.9K
Total Sold
$7.9K
Avg Position
$8.0K

Biggest Buyers

InstitutionNet Bought
+$81.0K
+61.8K shares
+$77.2K
+59.0K shares
+$438.0
+334.0 shares
MORGAN STANLEY logo
MORGAN STANLEY
RIA/Wealth
+$181.0
+-11.8K shares
+$47.0
+-15.5K shares
BlackRock, Inc. logo
BlackRock, Inc.
Institution
+$2.6
+2.0 shares
+$1.0
+1.0 shares

Biggest Sellers

InstitutionNet Sold
$2.6K
681.0 shares
$2.5K
667.0 shares
UBS Group AG logo
UBS Group AG
Institution
$2.1K
1.6K shares
$597.6
457.0 shares
$8.0
2.0 shares
$4.0
1.0 shares

Entry and Exit Activity

Institutions that initiated new positions or completely exited OGEN in Q3 2025

New Positions
2
New Value
$81.4K
Exited Positions
4
Exited Value
$5.2K

New Positions

InstitutionPosition Value
$81.0K
61.8K shares
$438.0
334.0 shares

Exited Positions

InstitutionPrevious Position
$2.6K
681.0 shares
$2.5K
667.0 shares
$8.0
2.0 shares
$4.0
1.0 shares

Options Activity

Institutions with the largest Call and Put options positions in OGEN as of Q3 2025

Call Positions
0
Call Value
-
Put Positions
0
Put Value
-

Call Positions

InstitutionPosition Value
No call positions found

Put Positions

InstitutionPosition Value
No put positions found

Most Committed Institutions

Institutions with OGEN as the highest % of their portfolio as of Q3 2025

InstitutionPortfolio Weight
0.42%
$77.2K
0.00%
$81.0K
0.00%
$272.0
0.00%
$438.0
0.00%
$45.0
C
CHESAPEAKE ASSET MANAGEMENT LLC
Hedge FundLong/Short
0.00%
$1.0
0.00%
$13.0
0.00%
$2.0
0.00%
$1.0
UBS Group AG logo
UBS Group AG
Institution
0.00%
$355.0

Hedge Fund Spotlight

Discover hedge funds investing in OGEN

C
CHESAPEAKE ASSET MANAGEMENT LLC
Hedge FundLong/Short
Portfolio ManagerGerasimos J Efthimiatos
Portfolio Value
$113.1M
Positions
293
Last Reported
Q3 2025
AddressNew York, NY
Sector Allocation
Technology: 27.00%TechnologyIndustrials: 11.90%IndustrialsFinancial Services: 11.40%Financial ServicesHealthcare: 10.30%HealthcareETF: 8.20%ETFCommunication Services: 6.90%Consumer Defensive: 4.40%Energy: 3.90%Consumer Cyclical: 2.90%Real Estate: 2.20%Utilities: 2.20%Basic Materials: 0.30%
Oragenics logo

Position in Oragenics

Market Value
$1.0
Shares Held
1.0
Portfolio Weight
0.00%
Owned Since
2025-Q2
Top HoldingSectorMarket ValueWeight
Software - Infrastructure
Technology
$11.8M10.47%
2
Apple logo
Apple
AAPL
Consumer Electronics
Technology
$7.4M6.54%
Drug Manufacturers - General
Healthcare
$6.8M5.98%

Cookie Preferences

We use cookies for analytics. See our Privacy and Cookie Policy.